PMC9584770_01
Echocardiogram performed on July 31, 2020 showing a 4.97x2.72 cm mass-like echogenicity on the right ventricular free wall.
CMAR-14-3063-g0001.jpg
PMC9584770_01_CMAR-14-3063-g0001.jpg
f0001
However, echocardiography performed on July 31, 2020, which was recommended owing to chest pain, revealed a 4.97x2.72 cm mass-like echogenicity adhering to the right ventricular free wall (Figure 1).
Chest computed tomography performed on August 6, 2020, showing a new lesion in the right ventricle near the pulmonary valve.
CMAR-14-3063-g0002.jpg
PMC9584770_01_CMAR-14-3063-g0002.jpg
f0002
Furthermore, chest CT performed on August 6, 2020, demonstrated a new lesion in the right ventricle near the pulmonary valve, and metastasis in the pericardium was ruled out (Figure 2).
PET scan image of the heart on August 14, 2020, revealing increased FDG uptakes in the right submandibular and mediastinal lymph nodes, bilateral lungs, heart, and pericardium which impress metastases.
CMAR-14-3063-g0003.jpg
PMC9584770_01_CMAR-14-3063-g0003.jpg
f0003
Service for further survey and treatment. Subsequent whole-body PET performed on August 14, 2020 revealed metastases in the right submandibular and mediastinal lymph nodes, bilateral lungs, heart, and pericardium (Figure 3).
Cardiac magnetic resonance imaging on August 19, 2020, revealing a lobulated and infiltrative enhancing soft tissue mass, mainly located in the anterior wall of the right ventricle.
CMAR-14-3063-g0004.jpg
PMC9584770_01_CMAR-14-3063-g0004.jpg
f0004
On August 19, 2020, cardiac magnetic resonance imaging revealed a lobulated and infiltrative enhancing soft tissue mass (measuring approximately 4.5 cm), mainly located in the anterior wall of the right ventricle, with heterogeneous contrast enhancement and an increase in pericardial effusion (Figure 4).